Table 2.
Correlation of biomarkers in the peripheral blood at baseline with change of plaque burden or morphology in the follow-up scan.
| Biomarker | Overall plaque change (n = 29/54 [54%])
|
New noncalcified plaque (n = 17/54 [31%])
|
New calcified plaque (n = 24/54 [44%])
|
Change of plaque morphology (n = 12/54 [22%])
|
||||
|---|---|---|---|---|---|---|---|---|
| r | P | r | P | r | P | r | P | |
| hs-TnT | 0.29 | .04 | 0.07 | .60 | 0.30 | .03 | 0.30 | .03 |
| hs-CRP | 0.40 | .004 | 0.23 | .10 | 0.14 | .32 | −0.23 | .10 |
hs-CRP, high-sensitivity C-reactive protein; hs-TnT, high-sensitivity troponin T; n, number of patients. All correlations are adjusted for age, gender and follow-up time.